This session shares the latest information on pharmaceutical treatments for infectious diseases in the older adult population.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/26/2024.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Pamela Cacchione, PhD, CRNP, BC, FGSA, FAAN, discloses that she receives royalties as editor-in-chief of Clinical Nursing Research an International Journal published by SAGE publishing. She also discloses that she serves as a consultant for Jonas Philanthropies.

There are no other Planning Committee disclosures to declare.

Speakers Disclosures:
Jason Gallagher, PharmD, BCPS, FCCP, FIDP, FIDSA, discloses that he serves as a consultant for Merck, Spero, Qpex, and Astellas. He also discloses that he receives other financial/material support via a grant from Merck.

There are no other speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).

Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.

Learning Outcome:
After completing this learning activity, the participant will be able to describe updated pharmaceutical treatments for infectious diseases in the older adult population.